Acute and preventive treatment of migraine headache

Lipton, 2007, Migraine prevalence, disease burden, and the need for preventive therapy, Neurology, 68, 343, 10.1212/01.wnl.0000252808.97649.21 Lipton, 2001, Prevalence and burden of migraine in the United States: data from the American Migraine Study II, Headache, 41, 646, 10.1046/j.1526-4610.2001.041007646.x Dodick, 2001, Acute and prophylactic management of migraine, Clin Cornerstone, 4, 36, 10.1016/S1098-3597(01)90038-9 Haque, 2012, Precipitating and relieving factors of migraine versus tension type headache, BMC Neurol, 12, 82, 10.1186/1471-2377-12-82 Silberstein, 2000, Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review), Neurology, 55, 754, 10.1212/WNL.55.6.754 Silberstein, 1997, Preventive treatment of migraine: an overview, Cephalalgia, 17, 67, 10.1046/j.1468-2982.1997.1702067.x Lipton, 2000, Stratified care vs step care strategies for migraine. The Disability in Strategies of Care (DISC) study: a randomized trial, J Am Med Assoc, 284, 2599, 10.1001/jama.284.20.2599 Lipton, 2000, Migraine: diagnosis and assessment of disability, Rev Contemp Pharmacother, 11, 63 Ramadan NM, Silberstein SD, Freitag FG, Gilbert TT, Frishberg BM. Evidence-based guidelines for migraine headache in the primary care setting: pharmacological management for prevention of migraine. Neurology [serial online]: Available at: 〈http://www.neurology.org〉; 2000 Accessed 25.04.00. Burstein, 2000, Defeating migraine pain with triptans: a race against the development of cutaneous allodynia, Ann Neurol, 55, 19, 10.1002/ana.10786 Belvis, 2009, Individual triptan selection in migraine attack therapy, Recent Patents CNS Drug Discov, 4, 70, 10.2174/157488909787002555 Silberstein, 2000, Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology, Neurology, 55, 754, 10.1212/WNL.55.6.754 Loder, 2010, Triptan therapy in migraine, N Engl J Med, 363, 63, 10.1056/NEJMct0910887 Bigal, 2003, Ergotamine and dihydroergotamine: a review, Curr Pain Headache Rep, 7, 55, 10.1007/s11916-003-0011-7 Saper, 2006, Pharmacology of dihydroergotamine and evidence for efficacy and safety in migraine, Headache, 46, S171, 10.1111/j.1526-4610.2006.00601.x Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders. 2nd ed. Cephalagia 2004;24(suppl 1):1-160. Klapper, 1992, Clinical experience with patient administered subcutaneous dihydroergotamine mesylate in refractory headaches, Headache, 32, 21, 10.1111/j.1526-4610.1992.hed3201021.x Cady, 2000, Treatment of mild headache in disabled migraine sufferers: results from the Spectrum Study, Headache, 40, 792, 10.1046/j.1526-4610.2000.00144.x Mathew, 2011, Headache, Semin Neurol, 31, 5, 10.1055/s-0031-1271313 Rizzoli, 2012, Acute and Preventive treatment of migraine, Continuum: Lifelong Learning Neurol, 18, 764 Tepper, 2006, Acute treatment of migraine, Continuum: Lifelong Learning Neurol, 12, 87 Diener, 2005, Cephalalgia, 25, 776, 10.1111/j.1468-2982.2005.00948.x Loder E, Rizzoli P, Burch R. The 2012 AHS/AAN Guidelines for Prevention of Episodic Migraine: a summary and comparison with other recent clinical practice guidelines. Headache. 2012; 52:930-945 Silberstein, 2006, Preventive treatment, Continuum: Lifelong Learning Neurol, 12, 104 Silberstein, 2012, Evidence-based guideline update: Pharmacologic treatment for episodic migraine prevention in adults: Report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society, Neurology, 78, 1337, 10.1212/WNL.0b013e3182535d20 Klapper, 1994, An open label cross-over comparison of divalproex sodium and propranolol HCl in the prevention of migraine headaches, Headache Q, 5, 50 Mathew N, Saper J, Magnus-Miller L. Efficacy and safety of gabapentin (Neurontin®) in migraine prophylaxis. 17th Annual Meeting of the American Pain Society Program Book. San Diego, CA. November 5-8, 1998 [Abstract 645]. Rompel, 1970, Aetiology of migraine and prevention with carbamazepine (Tegretol): results of a double-blind, cross-over study, S Afr Med J, 44, 75 Steiner, 1997, Lamotrigine versus placebo in the prophylaxis of migraine with and without aura, Cephalalgia, 17, 109, 10.1046/j.1468-2982.1997.1702109.x Couch, 1976, Migraine and depression: effect of amitriptyline prophylaxis, Trans Am Neurol Assoc, 101, 234 Ziegler, 1987, Migraine prophylaxis: a comparison of propranolol and amitriptyline, Arch Neurol, 44, 486, 10.1001/archneur.1987.00520170016015